Seeking Alpha
 

InterMune, Inc. (ITMN)

- NASDAQ
ITMN is defunct.
  • jw34 | Send Message 13 Nov 2014

    $ITMN when is their Q3 analyst call?
    Reply
      • Stephen Simpson, CFA | Send Message 26 Aug 2014

        With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune $RHHBY, $ITMN http://seekingalpha.com/a/1gidh
        Reply
          • William O'Neil | Send Message 25 Aug 2014

            $ITMN $RHHBY William Blair Raises InterMune's Price Target To $74 Following Acquisition By Roche http://bit.ly/1wtfgbr
            Reply
              • Capitalist Bull | Send Message 25 Aug 2014

                Traders Remain Frustrated Despite Record All Time Market High http://bit.ly/1wsS4Kq $SPY $QQQ $PCLN $ATHM $ITMN $JD $FB $BITA $EMES
                Reply
                  • Vetr | Send Message 25 Aug 2014

                    InterMune Acquisition Could Ignite These Biotech ETFs $FBT $IDIX $ITMN $XBI $MRK $PBE http://bit.ly/1qh2mYV
                    Reply
                      • MyHappyTrading | Send Message 25 Aug 2014

                        Weekly Wrap-Up + Market Forecast + Sector Watch: SPX, Nasdaq, ITMN, VRTX, BIIB, GILD,... $ITMN, $VRTX, $BIIB http://seekingalpha.com/p/1wk7z
                        Reply
                          • SA Editor Daniel Shvartsman | Send Message 25 Aug 2014
                            Reply
                              • Dereck | Send Message 24 Aug 2014

                                Congratulation to all $ITMN investors. Multi bagger of the year.
                                Reply
                                  • Joe Springer | Send Message 24 Aug 2014
                                    Reply (4)
                                  • View all 4 replies
                                    • hatvani | Send Message 25 Aug 2014
                                      : Look at ITMN's chart this year. It was in the low teens just in April.
                                    • CC1972 | Send Message 25 Aug 2014
                                      : Why is TNXP so under the radar?
                                      • freefdawatchlist | Send Message 24 Aug 2014

                                        http://bit.ly/1AKMAt2 Roche buy $ITMN for $8.3 billion $ITMN thats $74. Unsual Option Activity Sept $55 call OI 6k, and $60 call 3k
                                        Reply
                                          Visit Seeking Alpha's
                                          Company Description
                                          InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States